| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $41.9M | +87.1% | -59.1% |
| R&D Expense | $64.7M | -5.7% | -25.5% |
| SG&A Expense | $21.0M | -17.0% | -72.3% |
| Operating Income | -$43.8M | +38.7% | +27.4% |
| Pre-tax Income | -$34.8M | +43.4% | +28.4% |
| Income Tax | $300K | +200.0% | -50.0% |
| Net Income | -$35.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $101.5M | -11.7% | +19.1% |
| Short-term Investments | $686.1M | -8.1% | -33.8% |
| Accounts Receivable | $20.3M | +3960.0% | +178.1% |
| Current Assets | $826.3M | -7.1% | -28.1% |
| Total Assets | $844.3M | -7.1% | -27.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$243.4M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | $261.8M | — | — |
| Financing Cash Flow | -$17.4M | — | — |
| Free Cash Flow | -$245.1M | — | — |
| +42.6% |
| +28.7% |
| EPS (Basic) | -$0.48 | +42.9% | +29.4% |
| EPS (Diluted) | -$0.48 | +42.9% | +29.4% |
| $144.9M |
| -8.2% |
| -47.5% |
| Long-term Debt | $600K | -14.3% | -25.0% |
| Total Liabilities | $279.9M | -6.7% | -51.8% |
| Stockholders' Equity | $564.4M | -7.4% | -3.7% |